Merck acquisition
「Merck acquisition」熱門搜尋資訊
「Merck acquisition」文章包含有：「AcquisitionsandDivestments」、「Acquisition-Unity」、「MercktoAcquireEyeBio」、「MerckCompletesAcquisitionofEyeBio」、「Definite-Agreement-Mirus」、「Merckstillinthemarketfordealsinthe$1Bto$15Brange」、「Acquisitionsanddivestments」、「MercktobuyPrometheusBiosciencesforabout$11billion」、「MerckcompletesacquisitionofHarpoonTherapeutics」、「MercktoAcquireHarpoonTherapeuticsinDealValuedat...」
查看更多
Acquisitions and Divestments
https://www.merckgroup.com
Acquisitions and Divestments: Here you can find the list which offers extensive information about Merck's past acquisitions and divestments.
Acquisition-Unity
https://www.merckgroup.com
Merck intends to acquire Unity-SC, a provider of metrology and inspection instrumentation for the semiconductor industry.
Merck to Acquire EyeBio
https://www.merck.com
Under the terms of the agreement, Merck, through a subsidiary, will acquire all outstanding shares of EyeBio for up to $3 billion, including an ...
Merck Completes Acquisition of EyeBio
https://www.merck.com
Under the terms of the agreement, Merck, through a subsidiary, has acquired all outstanding shares of EyeBio. As previously disclosed, this ...
Definite-Agreement-Mirus
https://www.merckgroup.com
Merck, a leading science and technology company, has signed a definitive agreement to acquire life science company Mirus Bio for US$ 600 million ...
Merck still in the market for deals in the $1B to $15B range
https://www.fiercepharma.com
Merck made the biopharma industry's second-largest deal of 2021 when it acquired Acceleron for $11.5 billion. Last year, Merck's $10.8 ...
Acquisitions and divestments
https://www.merckgroup.com
Acquisitions in the previous year. Acquisition of Exelead Inc., United States. On December 30, 2021, Merck signed a definitive agreement to ...
Merck to buy Prometheus Biosciences for about $11 billion
https://www.reuters.com
Merck will pay $200 per share for the California-based biotechnology company that specializes in treatments for autoimmune diseases, ...
Merck completes acquisition of Harpoon Therapeutics
https://www.pharmaceutical-tec
Merck (MSD) has concluded the acquisition of all the outstanding shares of US-based Harpoon Therapeutics to broaden its oncology pipeline.
Merck to Acquire Harpoon Therapeutics in Deal Valued at ...
https://www.pharmtech.com
8, 2024 that they have entered into a definitive agreement for Merck to acquire Harpoon via a Merck subsidiary. Merck will acquire Harpoon for ...